AIZ vs BIIB · P/E 15, rev $3.45B vs P/E 21, rev $9.89B
Assurant Inc (AIZ) versus Biogen Inc (BIIB) — a side-by-side from cached financials, not a winner call.
Assurant Inc (AIZ) is a insurance - property & casualty company listed on US.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Latest reported AIZ revenue for 2026-06-30 was $3.45B. Net income was $298.6M. Revenue was up 1.0% from 2026-03-31 to 2026-06-30. AIZ currently screens at market cap $9.98B and trailing P/E 15.4.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
AIZ currently screens at market cap $9.98B and trailing P/E 15.4. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Not investment advice. Open the AIZ and BIIB stock pages for the full models.
Not investment advice.